Voena Claudia, Conte Chiara, Ambrogio Chiara, Boeri Erba Elisabetta, Boccalatte Francesco, Mohammed Shabaz, Jensen Ole N, Palestro Giorgio, Inghirami Giorgio, Chiarle Roberto
Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy.
Cancer Res. 2007 May 1;67(9):4278-86. doi: 10.1158/0008-5472.CAN-06-4350.
Anaplastic large cell lymphomas (ALCL) are mainly characterized by the reciprocal translocation t(2;5)(p23;q35) that involves the anaplastic lymphoma kinase (ALK) gene and generates the fusion protein NPM-ALK with intrinsic tyrosine kinase activity. NPM-ALK triggers several signaling cascades, leading to increased cell growth, resistance to apoptosis, and changes in morphology and migration of transformed cells. To search for new NPM-ALK interacting molecules, we developed a mass spectrometry-based proteomic approach in HEK293 cells expressing an inducible NPM-ALK and identified the tyrosine phosphatase Shp2 as a candidate substrate. We found that NPM-ALK was able to bind Shp2 in coprecipitation experiments and to induce its phosphorylation in the tyrosine residues Y542 and Y580 both in HEK293 cells and ALCL cell lines. In primary lymphomas, antibodies against the phosphorylated tyrosine Y542 of Shp2 mainly stained ALK-positive cells. In ALCL cell lines, Shp2-constitutive phosphorylation was dependent on NPM-ALK, as it significantly decreased after short hairpin RNA (shRNA)-mediated NPM-ALK knock down. In addition, only the constitutively active NPM-ALK, but not the kinase dead NPM-ALK(K210R), formed a complex with Shp2, Gab2, and growth factor receptor binding protein 2 (Grb2), where Grb2 bound to the phosphorylated Shp2 through its SH2 domain. Shp2 knock down by specific shRNA decreased the phosphorylation of extracellular signal-regulated kinase 1/2 and of the tyrosine residue Y416 in the activation loop of Src, resulting in impaired ALCL cell proliferation and growth disadvantage. Finally, migration of ALCL cells was reduced by Shp2 shRNA. These findings show a direct involvement of Shp2 in NPM-ALK lymphomagenesis, highlighting its critical role in lymphoma cell proliferation and migration.
间变性大细胞淋巴瘤(ALCL)主要特征是2号染色体和5号染色体发生相互易位t(2;5)(p23;q35),该易位涉及间变性淋巴瘤激酶(ALK)基因,并产生具有内在酪氨酸激酶活性的融合蛋白NPM-ALK。NPM-ALK触发多个信号级联反应,导致细胞生长增加、抗凋亡能力增强以及转化细胞的形态和迁移发生改变。为了寻找新的与NPM-ALK相互作用的分子,我们在表达可诱导NPM-ALK的HEK293细胞中开发了一种基于质谱的蛋白质组学方法,并鉴定酪氨酸磷酸酶Shp2为候选底物。我们发现在共沉淀实验中NPM-ALK能够结合Shp2,并在HEK293细胞和ALCL细胞系中诱导其酪氨酸残基Y542和Y580发生磷酸化。在原发性淋巴瘤中,针对Shp2磷酸化酪氨酸Y542的抗体主要染色ALK阳性细胞。在ALCL细胞系中,Shp2的组成型磷酸化依赖于NPM-ALK,因为在短发夹RNA(shRNA)介导的NPM-ALK敲低后其显著降低。此外,只有组成型活性NPM-ALK,而不是激酶失活的NPM-ALK(K210R),与Shp2、Gab2和生长因子受体结合蛋白2(Grb2)形成复合物,其中Grb2通过其SH2结构域结合磷酸化的Shp2。通过特异性shRNA敲低Shp2可降低细胞外信号调节激酶1/2以及Src激活环中酪氨酸残基Y416的磷酸化,导致ALCL细胞增殖受损和生长劣势。最后,Shp2 shRNA可减少ALCL细胞的迁移。这些发现表明Shp2直接参与NPM-ALK淋巴瘤的发生,突出了其在淋巴瘤细胞增殖和迁移中的关键作用。